Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
13.64
+0.08 (0.59%)
Nov 3, 2026, 11:08 AM EST - Market open

AAPG Stock Forecast

Stock Price Forecast

According to 11 analysts polled by S&P Global, AAPG stock has a consensus rating of "Strong Buy" and an average price target of $44.5. The average 1-year stock price forecast is 226.25% higher than the current stock price, while the lowest is $33 (+141.94%) and the highest is $55 (+303.23%).

Price Target: $44.5 (+226.25%)
Analyst Consensus: Strong Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$33$44.5$45.5$55
Change+141.94%+226.25%+233.58%+303.23%

Analyst Ratings

The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy677668
Buy222223
Hold000000
Sell000000
Strong Sell000000
Total8998811

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Citi
Citi
Buy
Initiates
$46
BuyInitiates$46+237.24%Oct 14, 2026
Citizens JMP
Citizens JMP
Buy
Initiates
$35
BuyInitiates$35+156.60%Oct 13, 2026
J.P. Morgan
J.P. Morgan
Buy
Maintains
$46 → $33
BuyMaintains$46 → $33+141.94%Oct 8, 2026
B. Riley Securities
B. Riley Securities
Buy
Maintains
$45
BuyMaintains$45+229.91%Sep 2, 2026
BTIG
BTIG
Buy
Maintains
$48
BuyMaintains$48+251.91%Aug 21, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
680.83M
from 574.12M
Increased by 18.59%
Revenue Next Year
1.50B
from 680.83M
Increased by 120.05%
EPS This Year
-3.94
from -3.49
EPS Next Year
-0.33
from -3.94
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
27.91M209.71M221.98M980.65M574.12M680.83M
Revenue Growth
124.18%651.38%5.85%341.77%-41.46%18.59%
Gross Profit
24.58M187.71M191.44M951.57M525.18M643.04M
Gross Margin
88.08%89.51%86.24%97.03%91.48%94.45%
Operating Income
-933.17M-883.41M-891.99M-378.80M-1.21B-1.49B
Net Income
-782.42M-882.92M-925.64M-405.43M-1.24B-1.53B
EPS
-----3.49-3.94
Free Cash Flow
-----1.20B-1.48B
No. Analysts
-----8
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.

Revenue Forecast

Revenue202620272028
High879.4M
Avg680.8M
Low614.1M

Revenue Growth

Revenue Growth202620272028
High
53.2%
Avg
18.6%
Low
7.0%

EPS Forecast

EPS202620272028
High-3.84
Avg-3.94
Low-4.03

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-